International GAAP® 2019: Generally Accepted Accounting Practice under International Financial Reporting Standards

Home > Other > International GAAP® 2019: Generally Accepted Accounting Practice under International Financial Reporting Standards > Page 385
International GAAP® 2019: Generally Accepted Accounting Practice under International Financial Reporting Standards Page 385

by International GAAP 2019 (pdf)


  a liability and an expense is recognised on signing the enforceable contract,

  measured at the fair value of the 5 instalments of €200,000.

  • Under Option 4, the contract is unenforceable and the donation is subject to a

  condition. In these circumstances, whether there is a constructive obligation to make

  the donation is a matter of judgement. Management might conclude that no

  constructive obligation exists until it is probable that the condition is met (which might

  not be until the additional funds have been collected). Only then would a liability and

  expense be recognised, measured at the net present value of the €1m promised.

  • Option 5 involves an enforceable contract which may give rise to a liability when

  the contract is signed. However, there is an exchange of benefits relating to the

  research and development activities performed on behalf of the entity. Whether

  these benefits have a value of at least the present value of the 5 instalments of

  €200,000 is a matter of judgement. If it is determined that this is an exchange

  transaction that is not onerous, the entity could regard the signing of the contract

  as executory and could apply the criteria in IAS 38 to determine whether an asset

  or expense would be recognised for the related research and development costs as

  incurred (see Chapter 17 at 6.2).

  Where the arrangement gives rise to an exchange transaction rather than a donation, the

  expenditure incurred by the donor is recorded in accordance with the relevant IFRS.

  Provisions, contingent liabilities and contingent assets 1949

  6.15 Settlement

  payments

  A similar issue to that discussed at 6.14 above arises when an entity promises to make a

  settlement payment in cases where an entity believes that there is no present legal

  obligation. For example, an entity dismisses an employee for behaving in a manner

  which breaches their employment contract. The entity determines that it has no present

  legal obligation under the terms of the employment contract or employment law, but

  promises to make a settlement payment to the former employee in order to avoid future

  possible lawsuits and unfavourable publicity. It can be difficult to determine whether a

  past obligating event exists that requires a provision to be recognised before payment

  to the employee is made.

  Where there is no legal obligation to make the payments, a liability is recognised when

  a constructive obligation arises. It is a matter of judgement whether and when a

  constructive obligation exists. A binding agreement to make a payment to the former

  employee could give rise to a legal obligation. In the absence of facts and circumstances

  that would create a constructive or legal obligation prior to settlement, the entity would

  recognise the settlement as an expense when the cash is transferred.

  7 DISCLOSURE

  REQUIREMENTS

  A significant distinction between the accounting treatment of provisions and other

  liabilities, such as trade payables and accruals, is the level of disclosure required.

  7.1 Provisions

  For each class of provision an entity should provide a reconciliation of the carrying

  amount of the provision at the beginning and end of the period showing:

  (a) additional provisions made in the period, including increases to existing provisions;

  (b) amounts used, i.e. incurred and charged against the provision, during the period;

  (c) unused amounts reversed during the period; and

  (d) the increase during the period in the discounted amount arising from the passage

  of time and the effect of any change in the discount rate.

  Comparative information is not required. [IAS 37.84].

  It is not clear whether disclosure (d) allows a single amount to be provided for the sum of

  the unwinding of the discount and any change in the provision resulting from a

  reassessment of the discount rate to be used or it requires these amounts to be given

  separately. However, given our view (discussed at 4.3.6 above) that only the charge for

  unwinding of the discount should be classified as a finance cost, with any further charge

  or credit that arises if discount rates have changed being recorded in the same line item

  that was used to establish the provision, it would make sense to disclose these items

  separately. It is also interesting that there is no specific requirement in the standard to

  disclose the discount rate used, especially where the effect of using a different discount

  rate could be material, such as in the measurement of a decommissioning provision.

  However, entities should remember that IAS 1 – Presentation of Financial Statements –

  requires disclosure of information about major sources of estimation uncertainty that have

  1950 Chapter 27

  a significant risk of resulting in a material adjustment to the carrying amounts of assets and

  liabilities within the next financial year. [IAS 1.125].

  One of the important disclosures which is reinforced here is the requirement to disclose

  the release of provisions found to be unnecessary. This disclosure, along with the

  requirement in the standard that provisions should be used only for the purpose for

  which the provision was originally recognised, [IAS 37.61], is designed to prevent entities

  from concealing expenditure by charging it against a provision that was set up for

  another purpose.

  In addition, for each class of provision an entity should disclose the following:

  (a) a brief description of the nature of the obligation and the expected timing of any

  resulting outflows of economic benefits;

  (b) an indication of the uncertainties about the amount or timing of those outflows. Where

  necessary to provide adequate information, an entity should disclose the major

  assumptions made concerning future events, as addressed in paragraph 48 of the

  standard (discussed at 4.4 above). This refers to future developments in technology and

  legislation and is of particular relevance to environmental liabilities; and

  (c) the amount of any expected reimbursement, stating the amount of any asset that

  has been recognised for that expected reimbursement. [IAS 37.85].

  Section D of the implementation guidance to the standard provides examples of suitable

  disclosures in relation to warranties and decommissioning costs.

  Most of the above disclosures are illustrated in the extract below, which includes the

  disclosure of provisions determined in accordance with IAS

  37, contingent

  consideration provisions which would be determined in accordance with IFRS 3, and

  employee provisions (included within Other provisions) which would be determined in

  accordance with IAS 19.

  Extract 27.8: Roche Holding Ltd (2017)

  Notes to the Roche Group Consolidated Financial Statements [extract]

  19.

  Provisions and contingent liabilities [extract]

  Provisions: movements in recognised liabilities in millions of CHF

  Contingent

  Environ-

  Restruct-

  considerati

  Legal

  mental

  uring

  on

  Other

  provisions

  provisions

  provisions

  provisions

  provisions Total

  Year ended 31 Dec
ember 2016

  At 1 January 2016

  700

  585

  621

  1,492

  1,238

  4,636

  Additional provisions created

  59 38 405 39 428

  969

  Unused amounts reversed

  (23)

  –

  (110)

  (447)

  (269)

  (849)

  Utilised (53)

  (119) (240) (69) (355) (836)

  Discount unwind3

  – 10 – 53 2

  65

  Business

  combinations

  – Acquired

  companies5

  – – – – –

  –

  – Deferred

  consideration5 –

  –

  –

  –

  –

  –

  – Contingent

  consideration5

  – – – – –

  –

  Currency translation effects

  22

  4

  (2)

  21

  18

  63

  At 31 December 2016

  705

  518

  674

  1,089

  1,062

  4,048

  Provisions, contingent liabilities and contingent assets 1951

  Current

  677 111 376 330 777

  2,271

  Non-current

  28 407 298 759 285

  1,777

  At 31 December 2016

  705

  518

  674

  1,089

  1,062

  4,048

  Year ended 31 December 2017

  At 1 January 2017

  705

  518

  674

  1,089

  1,062

  4,048

  Additional provisions created

  60 68 543 13 523

  1,207

  Unused amounts reversed

  (219)

  (4)

  (167)

  (366)

  (181)

  (937)

  Utilised (37)

  (81) (259) (146) (249) (772)

  Discount unwind3

  – 4 – 14 2

  20

  Business

  combinations

  – Acquired

  companies5

  – – – – –

  –

  – Deferred

  consideration5

  – – – – 8

  8

  – Contingent

  consideration5

  – – – 10 –

  10

  Currency translation effects

  (24)

  18

  31

  (23)

  4

  6

  At 31 December 2017

  485

  523

  822

  591

  1,169

  3,590

  Current

  471 119 450 182 820

  2,042

  Non-current

  14 404 372 409 349

  1,548

  At 31 December 2017

  485

  523

  822

  591

  1,169

  3,590

  Expected outflow of resources

  Within one year

  471

  119

  450

  182

  820

  2,042

  Between one and two years

  8

  164

  193

  103

  56

  524

  Between two and three years

  1

  138

  98

  94

  67

  398

  More than three years

  5

  102

  81

  212

  226

  626

  At 31 December 2017

  485

  523

  822

  591

  1,169

  3,590

  The Group has revised the presentation of provisions. Contingent consideration provisions are now presented

  separately and employee provisions are now included as part of ‘Other provisions’. The comparative period

  information has been restated accordingly. […]

  Legal provisions

  Legal provisions consist of a number of separate legal matters, including claims arising from trade, in various Group

  companies. By their nature the amounts and timings of any outflows are difficult to predict.

  As part of the regular review of litigation matters, management has reassessed the provisions recorded for certain

  litigation matters. Based on the development of the various litigations, notably the Accutane case, some of the

  provisions previously held were released, resulting in income of CHF 219 million in 2017. This was a major element

  in the 2017 legal expenses, which show a net income of CHF 142 million (2016: net expense of CHF 39 million).

  Details of the major legal cases outstanding are disclosed below.

  Environmental provisions

  Provisions for environmental matters include various separate environmental issues in a number of countries. By their

  nature the amounts and timings of any outflows are difficult to predict. Significant provisions are discounted by

  between 2% and 4% where the time value of money is material. The significant provisions relate to the US site in

  Nutley, New Jersey, which was divested in September 2016, the estimated remediation costs for a landfill site near

  Grenzach, Germany, that was used by manufacturing operations that were closed some years ago and the estimated

  remediation costs for the manufacturing site at Clarecastle, Ireland. In 2017 the expected costs of environmental

  remediation at the Clarecastle site were reassessed and accordingly the environmental provisions were increased by

  CHF 46 million. This was a major element of the 2017 environmental expenses, which show a net expense of CHF

  62 million (2016: net expense of CHF 38 million). […]

  1952 Chapter 27

  Restructuring provisions

  These arise from planned programmes that materially change the scope of business undertaken by the Group or the

  manner in which business is conducted. Such provisions include only the costs necessarily entailed by the restructuring

  which are not associated with the recurring activities of the Group. The timings of these cash outflows are reasonably

  certain. These provisions are not discounted as the time value of money is not material in these matters.

  In the Pharmaceuticals Division the significant provisions relate to the strategic realignment of the manufacturing

  network including exiting from four manufacturing sites, the resourcing flexibility plans to address various future

  challenges including biosimilar competition, the research and development strategic realignment and the outsourcing

  of IT functions to shared service centres and external providers (see Note 6).

  Other provisions

  Other provisions relate to items shown in the table below. With the exception of employee provisions, the timing of

  cash outflows is by its nature uncertain.

  Other provisions in millions of CHF

  2017 2016 2015

  Employee provisions

  362

  345

  313

  Sales returns

  366

  436

  616

  Other items

  441

  281

  309

  Total other provisions

  1,169 />
  1,062

  1,238

  The standard states that in determining which provisions may be aggregated to form a

  class, it is necessary to consider whether the nature of the items is sufficiently similar

  for a single statement about them to fulfil the requirements of (a) and (b) above. An

  example is given of warranties: it is suggested that, while it may be appropriate to treat

  warranties of different products as a single class of provision, it would not be

  appropriate to aggregate normal warranties with amounts that are subject to legal

  proceedings. [IAS 37.87]. For entities disclosing restructuring costs, this requirement could

  result in material components of the costs being disclosed separately. However,

  materiality will be an important consideration in judging how much analysis is required.

  As indicated at 6.1.1 above, IAS 37 emphasises that when a restructuring meets the

  definition of a discontinued operation under IFRS 5, additional disclosures may be

  required under that standard (see Chapter 4 at 3). [IAS 37.9].

  7.2 Contingent

  liabilities

  Unless the possibility of any outflow in settlement is remote, IAS 37 requires the

  disclosure for each class of contingent liability at the end of the reporting period to

  include a brief description of the nature of the contingent liability, and where

  practicable:

  (a) an estimate of its financial effect, measured in accordance with paragraphs 36-52

  of IAS 37 (discussed at 4 above);

  (b) an indication of the uncertainties relating to the amount or timing of any outflow; and

  (c) the possibility of any reimbursement. [IAS 37.86].

  Where any of the information above is not disclosed because it is not practicable to do

  so, that fact should be stated. [IAS 37.91].

  Provisions, contingent liabilities and contingent assets 1953

  The guidance given in the standard on determining which provisions may be aggregated

 

‹ Prev